BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Pharm Country

  VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) And Neurophysiological Investigations Of Brain Dopamine Regulation Of Metabolism With Eight Papers Presented At The 2015 American Diabetes Association Conference

  June 8, 2015

   · 

  4 min read
• Pharm Country

  Real-World Study Data Demonstrating That Valeritas’ V-Go Consistently Reduces A1C Levels And Decreases Insulin Requirements For Patients With Diabetes Regardless Of Baseline A1C Presented At American Diabetes Association 2015

  June 8, 2015

   · 

  4 min read
• Compugen Ltd. To Disclose Novel Cancer Immunotherapy Target Candidate And Comprehensive Target Characterization Infrastructure At Today’s Analyst And Investor Day

  June 8, 2015

   · 

  6 min read
• Avilex Pharma Receives Wellcome Trust Translation Award To Advance Their Ischemic Stroke Program And Raises In Total 28 MIO DKK (3.75 MIO EUR)

  June 8, 2015

   · 

  3 min read
• Policy

  Genmab A/S Announces Start Of Rolling Submission Of Biologics License Application For Daratumumab For Double Refractory Multiple Myeloma To The FDA

  June 8, 2015

   · 

  6 min read
• Pharm Country

  S1 BioPharma (Formerly Known As S1 Pharmaceuticals, Inc.) Supports FDA Advisory Committee’s Recommendation To Approve The First-Ever Treatment For Hypoactive Sexual Desire Disorder

  June 8, 2015

   · 

  1 min read
• BIOLASE Inc., The Global Leader In Dental Lasers, Features Groundbreaking Periodontal Protocol As Part Of Scientific Programme At Europerio 8, The World’s Leading Conference In Periodontology And Implant Dentistry

  June 8, 2015

   · 

  3 min read
• Biotech Bay

  Complete Genomics, Inc. Previews Revolocity Sequencing System At European Human Genetics Conference 2015

  June 8, 2015

   · 

  4 min read
• Drug Development

  Chimerix Completes Targeted Enrollment For Brincidofovir Phase III SUPPRESS Trial

  June 8, 2015

   · 

  7 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Completion Of Enrollment In Phase III Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis Type 7

  June 8, 2015

   · 

  5 min read